<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>pharmaphorum &#187; Articles</title>
	<atom:link href="http://www.pharmaphorum.com/category/articles/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.pharmaphorum.com</link>
	<description>Bringing Healthcare Together</description>
	<lastBuildDate>Wed, 08 Sep 2010 09:19:08 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>The strength of online patient communities</title>
		<link>http://www.pharmaphorum.com/2010/09/08/the-strength-of-online-patient-communities/</link>
		<comments>http://www.pharmaphorum.com/2010/09/08/the-strength-of-online-patient-communities/#comments</comments>
		<pubDate>Wed, 08 Sep 2010 08:46:50 +0000</pubDate>
		<dc:creator>Paul</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[Interviews]]></category>
		<category><![CDATA[internet]]></category>
		<category><![CDATA[patients]]></category>
		<category><![CDATA[social media]]></category>
		<category><![CDATA[technology]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2674</guid>
		<description><![CDATA[As pharmaphorum continues to interview key people changing the world of pharma, we caught up with Jeanne Barnett to hear more about CysticFibrosis.com.

It seems that an ever increasing volume of clinical study work is being conducted outside the mature global pharma markets... ]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/09/08/the-strength-of-online-patient-communities/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The pharma paradox</title>
		<link>http://www.pharmaphorum.com/2010/09/06/the-pharma-paradox/</link>
		<comments>http://www.pharmaphorum.com/2010/09/06/the-pharma-paradox/#comments</comments>
		<pubDate>Mon, 06 Sep 2010 07:34:44 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[branding]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[strategy]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2645</guid>
		<description><![CDATA[Chris Rose questions whether branding in pharma is an underrated, but viable option for protecting your assets.

Much speculation has been made about the “New Commercial Model” and how the pharma business will survive the threat of…]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/09/06/the-pharma-paradox/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>Trends in pharmaceutical R&amp;D outsourcing</title>
		<link>http://www.pharmaphorum.com/2010/09/03/trends-in-pharmaceutical-rd-outsourcing/</link>
		<comments>http://www.pharmaphorum.com/2010/09/03/trends-in-pharmaceutical-rd-outsourcing/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 08:59:03 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[outsourcing]]></category>
		<category><![CDATA[pharma]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2640</guid>
		<description><![CDATA[As pressure to cut costs in the pharma industry continues, Adwait Bhagwat discusses the increasing trend to outsource R&#038;D.

R&#038;D outsourcing involves pharmaceutical companies subcontracting parts of their R&#038;D efforts to third-party service providers...
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/09/03/trends-in-pharmaceutical-rd-outsourcing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What’s in a name?</title>
		<link>http://www.pharmaphorum.com/2010/08/31/what%e2%80%99s-in-a-name/</link>
		<comments>http://www.pharmaphorum.com/2010/08/31/what%e2%80%99s-in-a-name/#comments</comments>
		<pubDate>Tue, 31 Aug 2010 09:15:51 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[reform]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2631</guid>
		<description><![CDATA[As the number of terms used in nomenclature of marketing activities increases, Chris Stevenson questions whether it’s time we standardised.

 “That which we call a rose, by any other name would smell as sweet”. We may all agree with Juliet that her lover Romeo would...
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/31/what%e2%80%99s-in-a-name/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>pharmaphorum celebrates its first birthday!</title>
		<link>http://www.pharmaphorum.com/2010/08/27/pharmaphorum-celebrates-its-first-birthday/</link>
		<comments>http://www.pharmaphorum.com/2010/08/27/pharmaphorum-celebrates-its-first-birthday/#comments</comments>
		<pubDate>Fri, 27 Aug 2010 10:47:19 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[social media]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2623</guid>
		<description><![CDATA[As pharmaphorum celebrates its first birthday, Paul Tunnah reflects on a year of running a pharma social media site and looks forward to the future. 

Well, I can scarcely believe it myself, but pharmaphorum has reached its first birthday! The last year has certainly flown by, but...
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/27/pharmaphorum-celebrates-its-first-birthday/feed/</wfw:commentRss>
		<slash:comments>8</slash:comments>
		</item>
		<item>
		<title>What Are IDEAs Made Of: Efficacy</title>
		<link>http://www.pharmaphorum.com/2010/08/25/what-are-ideas-made-of-efficacy/</link>
		<comments>http://www.pharmaphorum.com/2010/08/25/what-are-ideas-made-of-efficacy/#comments</comments>
		<pubDate>Wed, 25 Aug 2010 08:03:29 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[market research]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2614</guid>
		<description><![CDATA[The term efficacy is used increasingly in the pharma industry. Mike Rea questions whether the term is used as a banner for anything that fits the bill.

Here's the thing about Efficacy. It doesn't exist. It is an abstract concept, a shorthand, a broad clustering of things that...
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/25/what-are-ideas-made-of-efficacy/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Looking beyond pharma for portfolio optimisation</title>
		<link>http://www.pharmaphorum.com/2010/08/23/looking-beyond-pharma-for-portfolio-optimisation/</link>
		<comments>http://www.pharmaphorum.com/2010/08/23/looking-beyond-pharma-for-portfolio-optimisation/#comments</comments>
		<pubDate>Mon, 23 Aug 2010 09:19:23 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2597</guid>
		<description><![CDATA[Trevor Brown outlines an exciting new project where pharma is looking to learn from other industries about how to improve portfolio management and optimisation.

Within an increasingly challenging environment, there is significant debate in the pharmaceutical industry directed at…
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/23/looking-beyond-pharma-for-portfolio-optimisation/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Engaging OLs ‘over time’ online for greater insight</title>
		<link>http://www.pharmaphorum.com/2010/08/19/engaging-ols-%e2%80%98over-time%e2%80%99-online-for-greater-insight/</link>
		<comments>http://www.pharmaphorum.com/2010/08/19/engaging-ols-%e2%80%98over-time%e2%80%99-online-for-greater-insight/#comments</comments>
		<pubDate>Thu, 19 Aug 2010 09:08:30 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[internet]]></category>
		<category><![CDATA[market research]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[social media]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2470</guid>
		<description><![CDATA[In a time-pressured, geographically-vast industry, Neil A. Jones discusses what should be considered to ensure effective online engagement with Opinion Leaders.

Despite all the promises of the web to engage opinion leaders and other key stakeholders online for… ]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/19/engaging-ols-%e2%80%98over-time%e2%80%99-online-for-greater-insight/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
		</item>
		<item>
		<title>A team management guide (part 2)</title>
		<link>http://www.pharmaphorum.com/2010/08/17/a-team-management-guide-part-2/</link>
		<comments>http://www.pharmaphorum.com/2010/08/17/a-team-management-guide-part-2/#comments</comments>
		<pubDate>Tue, 17 Aug 2010 09:09:32 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[career]]></category>
		<category><![CDATA[leadership]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[operations]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2493</guid>
		<description><![CDATA[In the second and final part of this two part series, Sue Wright highlights the remaining steps managers can take to develop and lead successful teams.

In the first part of this article, I introduced the seven key elements critical to success in leadership and covered off the first four...
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/17/a-team-management-guide-part-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What Are IDEAs Made Of: Brand names</title>
		<link>http://www.pharmaphorum.com/2010/08/13/what-are-ideas-made-of-brand-names/</link>
		<comments>http://www.pharmaphorum.com/2010/08/13/what-are-ideas-made-of-brand-names/#comments</comments>
		<pubDate>Fri, 13 Aug 2010 08:58:26 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[sales]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2547</guid>
		<description><![CDATA[Mike Rea returns to question whether sufficient consideration is put into drug brand names. Are we playing it too safe?  

This is not an industry that does what is easy instead of what is best.
This is not an industry that would ever...
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/13/what-are-ideas-made-of-brand-names/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
